Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Equity (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Return on Equity for 6 consecutive years, with 0.64% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 13.0% year-over-year to 0.64%, compared with a TTM value of 0.64% through Dec 2025, down 13.0%, and an annual FY2025 reading of 0.57%, down 12.0% over the prior year.
  • Return on Equity was 0.64% for Q4 2025 at Treace Medical Concepts, down from 0.54% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.11% in Q3 2021 and bottomed at 97.72% in Q1 2021.
  • Average Return on Equity over 5 years is 5.29%, with a median of 0.46% recorded in 2022.
  • The sharpest move saw Return on Equity tumbled -460bps in 2021, then surged 9742bps in 2022.
  • Year by year, Return on Equity stood at 0.22% in 2021, then crashed by -186bps to 0.62% in 2022, then skyrocketed by 41bps to 0.36% in 2023, then tumbled by -42bps to 0.51% in 2024, then fell by -25bps to 0.64% in 2025.
  • Business Quant data shows Return on Equity for TMCI at 0.64% in Q4 2025, 0.54% in Q3 2025, and 0.49% in Q2 2025.